Live Chart

O 670

H 670

L 670

VOL 319

Suven Pharmaceuticals Performance

Days Range

Low: ₹655.30
High: ₹673.30
Previous Close ₹667.30
Open ₹670.00
Volume 2,48,678
Day’s Range ₹655.30 - ₹673.30
52W Range ₹456.00 - ₹690.00
Market Cap ₹16,961 Cr

Fundamentals of Suven Pharmaceuticals

ROCE (TTM) 29.55%
P/E Ratio (TTM) 39.29
P/B Ratio 8.76
Industry P/E 32.27
Debt to Equity 0.03
ROE 22.31%
EPS (TTM) 16.96
Dividend Yield 0.9%
Book Value 76
Face Value 1

Financials of Suven Pharmaceuticals

Dec 2022Mar 2023Jun 2023Sep 2023
Net Sales353.77369.36347.55231.05
Profit before tax146.08166.21163.94105.41
Operating Profit107.72123.97120.5979.56
Net Profit107.72123.97120.5979.56
EPS in Rs4.234.874.743.13

About Suven Pharmaceuticals

Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company, incorporated on 6th November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) bas ... Read More

Parent Organisation Indian Private
Founded 2018
Managing Director J V Ramudu

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Supriya Lifescience Ltd ₹2,267.60


1.90 (0.67%)

280.1 - 286
Celestial Biolabs Ltd ₹4.56


0.00 (0.00)

1.75 - 1.8
JFL Life Sciences Ltd ₹48.23


0.10 (0.23%)

43.95 - 43.95
Procter & Gamble Health Ltd ₹8,522.36


38.80 (-0.76%)

5064 - 5143.95
Veerhealth Care Ltd ₹33.78


0.00 (0.00)

26 - 26

What's Trending


What is the Share price of Suven Pharmaceuticals (SUVENPHAR)?

Suven Pharmaceuticals (SUVENPHAR) share price as of December 6, 2023, on NSE is Rs 671.00 (NSE) and Rs 675.15 (BSE) on BSE.

Can I buy Suven Pharmaceuticals (SUVENPHAR) shares?

Yes, You can buy Suven Pharmaceuticals (SUVENPHAR) shares by opening a Demat account with Angel One.

How do I buy Suven Pharmaceuticals (SUVENPHAR) from Angel One?

Suven Pharmaceuticals (SUVENPHAR) share can be brought through the following modes:
  1. Direct investment: You can buy Suven Pharmaceuticals (SUVENPHAR) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Suven Pharmaceuticals (SUVENPHAR) shares.

Is Suven Pharmaceuticals a Debt free Company?

Suven Pharmaceuticals is virtually a debt free company.

What is the main business of Suven Pharmaceuticals?

Suven Pharma is involved in the contract development and manufacturing organisation (CDMO) that caters to the global Pharma Industry needs.

Who are the promoters of Suven Pharmaceuticals?

Jasti Property And Equity Holdings Private Limited is the promoter of Suven Pharmaceuticals.

What are the Subsidiaries that comes under Suven Pharmaceuticals?

Casper Pharma is a subsidiary comes under Suven Pharmaceuticals